Stocks and Investing Stocks and Investing
Thu, October 11, 2018

David Lewis Maintained (ABT) at Buy with Increased Target to $80 on, Oct 11th, 2018


Published on 2024-10-26 09:23:06 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $70 to $80 on, Oct 11th, 2018.

David has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $77 on, Monday, September 24th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $72 on, Thursday, July 19th, 2018
Contributing Sources